sciencetalk

Irritable bowel syndrome (IBS) is a common gastrointestinal disorder in the developed world. It is characterized by altered bowel function, abdominal discomfort, and pain. However, there are few effective treatments for IBS, in part because the molecular mechanisms underlying the disease symptoms have not been well defined. But now, researchers from the University of Calgary have provided evidence that serine proteases and PAR2 might provide new therapeutic targets for the treatment of IBS.


Lees meer...


Bron: ScienceDaily Headlines

Daily headlines about discoveries in the physical and life sciences, health and medicine, the environment, and technology, from the world's leading universities and research centers.